Repeatability of lung density measurements with low-dose computed tomography in subjects with α-1-antitrypsin deficiency - Associated emphysema

Investigative Radiology

Volumn 36, Issue 11, 2001, Pages 648-651

  Stolk, Jan ^a   Dirksen, Asger ^b   Van Der Lugt, Aad ^c   Hutsebaut, Jacques ^d   Mathieu, Jacques ^d   De Ree, Juliette ^a   Reiber, Johan H C ^a   Stoel, Berend C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c ERASMUS MEDICAL CENTER   (Netherlands)

^d Etterbeek Ixelles Hospital   (Belgium)

Author keywords

Computed tomography; Emphysema; Lung densities

Indexed keywords

ALPHA 1 ANTITRYPSIN;

ACCURACY; ADULT; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DENSITY; DISEASE COURSE; EMPHYSEMA; FEMALE; HUMAN; IMAGE ANALYSIS; LUNG; LUNG FUNCTION TEST; MALE; MEASUREMENT; PRIORITY JOURNAL; RADIATION DOSE; REPRODUCIBILITY;

EID: 0034764145     PISSN: 00209996     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004424-200111000-00004     Document Type: Article

References (13)

1. 1: The Lung Health Study
2. Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: A randomised controlled trial
3. CT measurements of lung density in life can quantitate distal airspace enlargements: An essential defining feature of human emphysema
4. Pulmonary emphysema: Subjective visual grading versus objective quantification with macroscopic morphometry and thin section CT densitometry
5. Progress of emphysema in severe α-1-antitrypsine deficiency as assessed by annual CT
6. Standardized lung function testing: Lung volumes and forced ventilatory flows
7. Assessment of the progression of emphysema by quantitative analysis of spirometrically gated computer tomography images
8. A randomized clinical trial of α-1-antitrypsin augmentation therapy
9. Reproducibility of spirometrically controlled CT lung densitometry in a clinical setting
10. Spirometry in the Lung Health Study, II: Determinants of short-term intraindividual variability
11. α-1-antitrypsin replacement therapy: Will its efficacy ever be proved?
12. α-1-antitrypsin deficiency: What next?